These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 18006606)

  • 1. Endocannabinoids and liver disease. II. Endocannabinoids in the pathogenesis and treatment of liver fibrosis.
    Siegmund SV; Schwabe RF
    Am J Physiol Gastrointest Liver Physiol; 2008 Feb; 294(2):G357-62. PubMed ID: 18006606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocannabinoids and liver disease. I. Endocannabinoids and their receptors in the liver.
    Mallat A; Lotersztajn S
    Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G9-G12. PubMed ID: 17975129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The endocannabinoid system as a novel target for the treatment of liver fibrosis].
    Teixeira-Clerc F; Julien B; Grenard P; Tran Van Nhieu J; Deveaux V; Hezode C; Mallat A; Lotersztajn S
    Pathol Biol (Paris); 2008 Feb; 56(1):36-8. PubMed ID: 17412522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocannabinoids as novel mediators of liver diseases.
    Mallat A; Lotersztajn S
    J Endocrinol Invest; 2006; 29(3 Suppl):58-65. PubMed ID: 16751709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocannabinoids and their role in fatty liver disease.
    Mallat A; Lotersztajn S
    Dig Dis; 2010; 28(1):261-6. PubMed ID: 20460921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the endocannabinoid system in liver diseases.
    Caraceni P; Domenicali M; Giannone F; Bernardi M
    Best Pract Res Clin Endocrinol Metab; 2009 Feb; 23(1):65-77. PubMed ID: 19285261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biology of hepatic stellate cells and their possible relevance in the pathogenesis of portal hypertension in cirrhosis.
    Pinzani M; Gentilini P
    Semin Liver Dis; 1999; 19(4):397-410. PubMed ID: 10643625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocannabinoid-mediated control of synaptic transmission.
    Kano M; Ohno-Shosaku T; Hashimotodani Y; Uchigashima M; Watanabe M
    Physiol Rev; 2009 Jan; 89(1):309-80. PubMed ID: 19126760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The endocannabinoid system and liver diseases.
    Caraceni P; Domenicali M; Bernardi M
    J Neuroendocrinol; 2008 May; 20 Suppl 1():47-52. PubMed ID: 18426499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic fibrosis, stellate cells, and portal hypertension.
    Rockey DC
    Clin Liver Dis; 2006 Aug; 10(3):459-79, vii-viii. PubMed ID: 17162223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastrointestinal endocannabinoid system: multifaceted roles in the healthy and inflamed intestine.
    Smid SD
    Clin Exp Pharmacol Physiol; 2008 Nov; 35(11):1383-7. PubMed ID: 18671715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the endocannabinoid system in atherosclerosis.
    Mach F; Steffens S
    J Neuroendocrinol; 2008 May; 20 Suppl 1():53-7. PubMed ID: 18426500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocannabinoids and the gastrointestinal tract.
    Massa F; Monory K
    J Endocrinol Invest; 2006; 29(3 Suppl):47-57. PubMed ID: 16751708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The endocannabinoid system modulates a transient TNF pathway that induces neural stem cell proliferation.
    Rubio-Araiz A; Arévalo-Martín A; Gómez-Torres O; Navarro-Galve B; García-Ovejero D; Suetterlin P; Sánchez-Heras E; Molina-Holgado E; Molina-Holgado F
    Mol Cell Neurosci; 2008 Jul; 38(3):374-80. PubMed ID: 18499473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabinoid receptors as therapeutic targets in the management of liver diseases.
    Mallat A; Lotersztajn S
    Drug News Perspect; 2008 Sep; 21(7):363-8. PubMed ID: 19259549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of the Hepatic Endocannabinoid and Apelin Systems in the Pathogenesis of Liver Fibrosis.
    Melgar-Lesmes P; Perramon M; Jiménez W
    Cells; 2019 Oct; 8(11):. PubMed ID: 31653030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The emerging functions of endocannabinoid signaling during CNS development.
    Harkany T; Guzmán M; Galve-Roperh I; Berghuis P; Devi LA; Mackie K
    Trends Pharmacol Sci; 2007 Feb; 28(2):83-92. PubMed ID: 17222464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutical targets for revert liver fibrosis].
    García B L; Gálvez G J; Armendáriz B J
    Rev Med Chil; 2007 Jun; 135(6):783-91. PubMed ID: 17728907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The endocannabinoid system and the regulation of the metabolism].
    Ducobu J
    J Pharm Belg; 2005; 60(3):84-8. PubMed ID: 16252509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocannabinoids in endocrine and related tumours.
    Bifulco M; Malfitano AM; Pisanti S; Laezza C
    Endocr Relat Cancer; 2008 Jun; 15(2):391-408. PubMed ID: 18508995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.